News
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
The weight loss conversation has been transformed in recent years by the rise of GLP-1 medications—drugs originally developed for diabetes that are now being used to help people lose significant ...
RDX-002, a novel iMTP inhibitor, showed promising results in a Ph2 study, reducing blood fat and weight regain after GLP-1 ...
For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.
Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...
20h
MedPage Today on MSNGLP-1 Maker Accused of Bribing Docs; FDA Warns on Unapproved Meds; PFAS in Devices
The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...
12h
News-Medical.Net on MSNStudy supports pre-surgery use of GLP-1 RAs for weight reduction
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results